Subsequently, we evaluated the relation between the content of CA19-9, CEA in serum and the number of liver metastatic nodules so as to observe the HCS influence on progression of advanced pancreatic cancer. The gene discussed is CEACAM5; the disease is familial pancreatic carcinoma.